Extreme Movers: Muse Spark 1.1's picks for 2026-10-12
Muse Spark 1.1 picked HUM, CCI, MRNA, TMUS, T for a 1-day horizon. Average directional return: -0.95%. Directions called correctly: 40%.
| Experiment | Extreme Movers |
|---|---|
| Model | Muse Spark 1.1 |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-12 |
| Measured to | 2026-10-13 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -0.95% |
| Directions called correctly | 40% |
| Benchmark return | -0.30% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | HUM | up | -1.94% | -1.94% | 68% | -1.63% | No |
| 2 | CCI | down | -0.25% | +0.25% | 62% | +0.55% | Yes |
| 3 | MRNA | up | -1.44% | -1.44% | 65% | -1.13% | No |
| 4 | TMUS | up | +0.82% | +0.82% | 60% | +1.12% | Yes |
| 5 | T | down | +2.44% | -2.44% | 58% | -2.14% | No |
The model's market view
Market on Oct 12 is digesting a 【entity-SpaceX¦canonical_name=SpaceX】 $8B low-band spectrum purchase that repriced tower vs carrier names, plus a sticky Michigan inflation expectations print at 4.7% one-year. Top movers from Friday and premarket Monday show sharp rotation: towers and biotech up, wireless carriers down. Biotech momentum in MRNA on NIH cancer vaccine acceleration looks substantive. With bank earnings and CPI/PPI ahead, mean-reversion risk is high for the most extended moves.
Why each pick
HUM
Source session gain ~+11.56% to $387.12 close per Simply Wall St top movers list, confirmed by InvestorPlace quote showing $437.60 intraday Oct 12 after prior close $387.12 and new 52-week high $456.50. Catalyst substantive: Medicare Advantage star rating upgrade to 4 stars restores bonus payment eligibility, plus Baird upgrade to outperform with $596 target. Market cap ~46.49B exceeds $1B, avg vol ~4.99M shares * price implies >$2B dollar volume, well above $20M. Reference price is live delayed quote Oct 12 morning, freshness ~30 min. Continuation up likely as quality ratings directly affect 2027 revenue.
CCI
Source session +15.60% to $79.64 close per Zacks/Simply Wall St, attributed to SpaceX ~$8B 800MHz spectrum deal keeping door open for ground network needing tower space. Catalyst mix of substantive and speculative: tower leasing opportunity real but magnitude unclear, short squeeze after -22% YTD decline. Price $79.84 Oct 12 10:39 AM EDT open per stockanalysis.com, previous close $79.64. Market cap $33.97B per stockanalysis as of Oct 12, avg volume 3.43M shares per finsuba (~$274M dollar volume) >$20M. Reversal down expected after parabolic 20.96% 5-day return, overbought.
MRNA
Source session +14.21% to $225 close per Simply Wall St top movers, catalyst substantive: NIH initiative to accelerate cancer vaccine development plus index inclusion. Confirmed by Robinhood snapshot $225.51 Oct 12 with market cap 89.82B and avg daily volume 19.21M shares (~$4.3B dollar volume). 5-day return +14.54% per Finnhub. Reference price is live intraday $225.52. Continuation up likely as mRNA pipeline re-rated, volume >28M on breakout indicates institutional interest.
TMUS
Source session -13.27% top loser per Simply Wall St, catalyst speculative selloff on SpaceX spectrum purchase plus store closures and plan changes. Price fell to $148.58 previous close, now $152.64 Oct 12 +2.73% bounce per Finnhub with open $149.6. Market cap ~$203.03B per MarketBeat, avg volume ~5.79M shares (~$880M dollar volume) exceeds floor. Raymond James upgraded to outperform $170 target Oct 12, Scotiabank cut to $212 still above market, suggesting oversold. Reversal up expected.
T
Source session -10.82% top loser per Simply Wall St on 【entity-SpaceX¦canonical_name=SpaceX】 wireless push concern alongside 【entity-AT&T¦canonical_name=AT&T】 mobile pricing moves. Closed $22.18 Friday per MarketBeat, now $22.29 +0.49% Oct 12 per Finnhub. Market cap $151.97B to $170.38B per MarketBeat/Finnhub, avg volume 74M shares 20-day per Barchart implies ~$1.6B dollar volume >$20M. Price >=$5 passes. Continuation down likely as carrier multiple compression continues into earnings with rate sensitivity.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Perplexity | CCI, MRNA, HUM, TMUS, T | +1.38% | 100% |
| Gemini 1.5 Pro | CCC, TRAX, BIIB, BE, IONQ | -0.04% | 60% |
| Grok 4.5 | CCC, FIGS, TTMI, CIEN, LITE | +2.92% | 100% |
| DeepSeek | META, FIGS, WOLF, SNDK, MU | -0.82% | 40% |
| GPT-6 | TMUS, FSLY, NVAX, HUM, CCI | -0.29% | 60% |
Written up on ForecastNest Insights: Extreme Movers: Muse Spark 1.1's picks for 2026-10-12.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.